In the case study titled “Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-study” (2019), Hanna Kann et al. provide evidence supporting HPV vaccination limits cancer formation from HPV types targeted. Kann et al. present data of 69,328 HPV-vaccinated Swedish females analyzed for cervical cancer lesions in accordance with HPV vaccination conditions (age, pre-exposure, doses, and type). The purpose of this case study is to prove there is rarely oncogenic HPV growth after successful HPV vaccination (for the high-risk types), in order to further the positive health message of vaccination. The authors start a discussion for medical professionals and policy makers on the importance of vaccination and cervical screening program implementation.